Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA

References

• Cahill S, Valadz R. Growing older with HIV/AIDS: new public health challenges. Am J Public Health 2013;103:e7-15
   PubMed Web of Science ®Google Scholar
• Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥ 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012;41:433-45
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. HIV/AIDS among Persons Aged 50 and Older, CDC HIV/AIDS Facts 2008. Available at: http://www.cdc.gov/hiv/group/age/olderamericans/ [Last accessed 23 March 2016]
   Google Scholar
• Guaraldi G, Prakash M, Moecklinghoff C, et al. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev 2014;16:75-89
   PubMed Web of Science ®Google Scholar
• Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging 2008;3:453-72
   PubMed Web of Science ®Google Scholar
• Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J 2014;35:1373-81
   PubMed Web of Science ®Google Scholar
• Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013;173:614-22
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011;53:1120-6
   PubMed Web of Science ®Google Scholar
• Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health 2012;12:234
   PubMed Web of Science ®Google Scholar
• Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 2008;93:3499-504
   PubMed Web of Science ®Google Scholar
• Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20:2165-74
   PubMed Web of Science ®Google Scholar
• Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007;44:1625-31
   PubMed Web of Science ®Google Scholar
• Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-12
   PubMed Web of Science ®Google Scholar
• Womack JA, Goulet JL, Gibert C, et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 2011;6:e17217
   PubMed Web of Science ®Google Scholar
• Ando M, Tsuchiya K, Nitta K. How to manage HIV infected patients with chronic kidney disease in the HAART era. Clin Exp Nephrol 2012;16:363-72
   PubMed Web of Science ®Google Scholar
• McComsey GA, Tebas P, Shane E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010;51:937-46
   PubMed Web of Science ®Google Scholar
• D:A:D Study Group, Sabin CA, Worm SW, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008;371:1417-26
   PubMed Web of Science ®Google Scholar
• Hsue PY, Scherzer R, Hunt PW, et al. Carotid intima–media thickness progression in HIV-infected adults occurs preferentially at the carotid bifurcation and is predicted by inflammation. J Am Heart Assoc 2012;1:jah3-e000422
   PubMed Web of Science ®Google Scholar
• Mocroft A, Kirk O, Reiss P, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010;24:1667-78
   PubMed Web of Science ®Google Scholar
• Yombi JC, Pozniak A, Boffito M, et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS 2014;28:621-32
   PubMed Web of Science ®Google Scholar
• Childs K, Welz T, Samarawickrama A, Post FA. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS 2012;26:253-62
   PubMed Web of Science ®Google Scholar
• Mills A, Crofoot G Jr, McDonald C, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate in the first protease inhibitor-based single-tablet regimen for initial HIV-1 therapy: a randomized phase 2 study. J Acquir Immune Defic Syndr 2015;69:439-45
   PubMed Web of Science ®Google Scholar
• System, USRDS. 2016 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2016. Available at: http://www.usrds.org/adr.aspx [Last accessed 21 February 2017]
   Google Scholar
• Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 2007;26:38-48
   PubMed Web of Science ®Google Scholar
• National Heart, Lung and Blood Institute. NHLBI Fact Book, Fiscal Year 2012. NHLBI, 2013. Available at: https://www.nhlbi.nih.gov/about/documents/factbook/2012 [Last accessed 24 Feb 2017]
   Google Scholar
• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2007;22:465-75
   PubMed Web of Science ®Google Scholar
• Thorsness R, Shields E, Iannuzzi JC, et al. Cost drivers after surgical management of proximal humerus fractures in medicare patients. J Orthop Trauma 2016;30:262-8
   PubMed Web of Science ®Google Scholar
• Quiros-Roldan E, Magoni M, Raffetti E, et al. The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population. BMC Public Health 2016;16:1146
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Zona S, Menozzi M, et al. Cost of noninfectious comorbidities in patients with HIV. Clinicoecon Outcomes Res 2013;5:481-8
   PubMedGoogle Scholar
• Gardner LI, Klein RS, Szczech LA, et al. Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr 2003;34:320-30
   PubMed Web of Science ®Google Scholar
• Oramasionwu CU, Morse GD, Lawson KA, et al. Hospitalizations for cardiovascular disease in African Americans and whites with HIV/AIDS. Popul Health Manag 2013;16:201-7
   PubMed Web of Science ®Google Scholar
• Solem CT, Snedecor SJ, Khachatryan A, et al. Cost of treatment in a US commercially insured, HIV-1–infected population. PLoS One 2014;9:e98152
   PubMed Web of Science ®Google Scholar
• Fleishman JA, Gebo KA, Reilly ED, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Med Care 2005;43:III40-52
   PubMed Web of Science ®Google Scholar
• AIDS info 2009. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2009. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf [Last accessed 1 December 2016]
   Google Scholar
• Mocroft A, Lundgren JD, Ross M, et al. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med 2015;12:e1001809
   PubMed Web of Science ®Google Scholar
• Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-6
   PubMed Web of Science ®Google Scholar
• Qian Y, Arellano J, Bhowmik D, et al. Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors. J Oncol Pharm Pract 2017;23:195-202
   PubMed Web of Science ®Google Scholar
• Tarride JE, Lim M, DesMeules M, et al. A review of the cost of cardiovascular disease. Can J Cardiol 2009;25:e195-202
   PubMed Web of Science ®Google Scholar
• Chapman RH, Liu LZ, Girase PG, et al. Determining initial and follow-up costs of cardiovascular events in a US managed care population. BMC Cardiovasc Disord 2011;11:11
   PubMed Web of Science ®Google Scholar
• Bonafede M, Shi N, Barron R, et al. Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 2016;11:26
   PubMed Web of Science ®Google Scholar
• Hopkins RB, Tarride JE, Leslie WD, et al. Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporos Int 2013;24:581-93
   PubMed Web of Science ®Google Scholar
• KCMU analysis of MEPS 3-year pooled data, 2004–2006. Medicaid enrollees are sicker and more disabled than the privately-insured. 2016. Available at: http://kff.org/medicaid/slide/medicaid-enrollees-are-sicker-and-more-disabled-than-the-privately-insured/ [Last accessed 19 December 2016]
   Google Scholar
• Crowell TA, Gebo KA, Balagopal A, et al. Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV. J Acquir Immune Defic Syndr 2014;65:429-37
   PubMed Web of Science ®Google Scholar
• Fleishman JA, Monroe AK, Voss CC, et al. Expenditures for persons living with HIV enrolled in Medicaid, 2006–2010. J Acquir Immune Defic Syndr 2016;72:408-15
   PubMed Web of Science ®Google Scholar